Best Supplements for Cardiovascular Health
Supplements with clinical evidence for heart disease prevention, blood pressure, triglycerides, and cardiovascular mortality.
Cardiovascular disease remains the leading cause of death globally. Several supplements have demonstrated meaningful effects on cardiovascular risk factors and clinical outcomes in large meta-analyses. We present the evidence honestly — including limitations that pharmaceutical-level trials have revealed.
Omega-3 (EPA/DHA)
Cochrane review of 86 RCTs (162,796 participants): reduced coronary heart disease events (RR=0.91), CHD mortality (RR=0.90). JACC 2022 meta-analysis (883,627 participants): omega-3 reduced CVD mortality (RR=0.93). Prescription EPA (Vascepa) showed 25% CVD event reduction at 4g/day in REDUCE-IT trial.
High EPA doses (4g+) increase atrial fibrillation risk (RR=1.35) and bleeding (RR=1.49). Combination EPA+DHA shows less cardiovascular benefit than EPA alone at equivalent doses.
CoQ10 (Ubiquinol)
JACC 2022 meta-analysis (884 RCTs, 883,627 participants): CoQ10 reduced all-cause mortality (RR=0.68). Q-SYMBIO trial: 300mg CoQ10 reduced major cardiac events by 43% in heart failure patients. Blood pressure reduction of -11 mmHg systolic in hypertension meta-analysis.
Evidence strongest in heart failure patients. General prevention benefit is less certain. May reduce warfarin efficacy — consult physician if on anticoagulants.
Magnesium
Meta-analysis of 34 RCTs: magnesium supplementation reduced systolic BP by 2 mmHg and diastolic by 1.78 mmHg. JACC 2022 found moderate-quality evidence for cardiovascular risk factor reduction. Mechanism: vasodilation via calcium channel modulation.
Blood pressure effect is modest and may only be meaningful in hypertensive individuals. Avoid high doses in kidney disease.
Vitamin D3
Despite strong observational data linking low vitamin D to cardiovascular disease, BMJ 2019 meta-analysis (52 RCTs, 75,454 participants) found no significant reduction in cardiovascular mortality (RR=0.98). The 16% cancer mortality reduction is the stronger evidence.
Vitamin D supplementation is still recommended for deficiency correction — but expectations for cardiovascular benefit should be tempered by RCT evidence, which is weaker than observational data suggests.
How We Rate Evidence
Browse other conditions
This analysis is based on peer-reviewed research retrieved from PubMed and the Cochrane Library. This is educational content, not medical advice. Always consult a healthcare provider before starting any supplement regimen, especially if you have a diagnosed condition or take medications.